Emory University and Winship Cancer Institute have received a funding award of up to $17.6 million from the ARPA-H to develop innovative AI-driven surgical practices for cancer patients.
MarginCall uses Fluorescence Imitating Brightfield Imaging (FIBI) to evaluate surgical margins during operations and assess whether cancerous cells have been entirely removed.
Developers hope MarginCall will significantly enhance patient outcomes and address challenges associated with surgical precision for cancer patients.
The MarginCall system will operate independent of an on-site pathologist, providing high-resolution images of surgical margins in near-real-time.
Emory University researchers, Anant Madabhushi and Farzad Fereidouni, will lead the project and introduce technological advancements in surgery, imaging, pathology, AI, and medicine.
Novel technological approaches aim to enhance the surgical process and offer a cost-effective alternative to traditional methods.
The new imaging technology promises to democratize advanced cancer care, especially in regions where access to specialized pathologists is limited.
Initial research focuses on breast and ovarian cancers but hopes to eventually broaden in the future.
MarginCall brings together experts in imaging, AI and medical technology to foster innovation and discovery.
Through this initiative, the team aims to not only advance surgical oncology but enhance the quality of life for cancer patients and bring a new age of patient care that is increasingly efficient, accurate, and accessible.